PathNet: A tool for pathway analysis using topological information

Source Code for Biology and Medicine

Volumn 7, Issue , 2012, Pages

  Dutta, Bhaskar ^a   Wallqvist, Anders ^a   Reifman, Jaques ^a  

^a U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

Author keywords

Canonical pathways; Pathway association; Pathway enrichment; Pathway interaction; Pathway topology

Indexed keywords

EID: 84866495994     PISSN: None     EISSN: 17510473     Source Type: Journal    
DOI: 10.1186/1751-0473-7-10     Document Type: Article

References (57)

1. Manoli T, Gretz N, Grone HJ, Kenzelmann M, Eils R, Brors B. Group testing for pathway analysis improves comparability of different microarray datasets. Bioinformatics 2006, 22(20):2500-2506.
2. Goeman JJ, Buhlmann P. Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics 2007, 23(8):980-987.
3. Da Huang W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37(1):1-13.
4. Liu Q, Dinu I, Adewale AJ, Potter JD, Yasui Y. Comparative evaluation of gene-set analysis methods. BMC Bioinformatics 2007, 8:431.
5. Fisher L, Van Belle G. Biostatistics: a methodology for the health sciences 1993, NewYork: Wiley.
6. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102(43):15545-15550.
7. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R. A systems biology approach for pathway level analysis. Genome Res 2007, 17(10):1537-1545.
8. Tarca AL, Draghici S, Khatri P, Hassan SS, Mittal P, Kim JS, Kim CJ, Kusanovic JP, Romero R. A novel signaling pathway impact analysis. Bioinformatics 2009, 25(1):75-82.
9. Thomas R, Gohlke JM, Stopper GF, Parham FM, Portier CJ. Choosing the right path: enhancement of biologically relevant sets of genes or proteins using pathway structure. Genome Biol 2009, 10(4):R44.
10. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008, 36(Database issue):D480-484.
11. Li Y, Agarwal P, Rajagopalan D. A global pathway crosstalk network. Bioinformatics 2008, 24(12):1442-1447.
12. Kelder T, Eijssen L, Kleemann R, van Erk M, Kooistra T, Evelo C. Exploring pathway interactions in insulin resistant mouse liver. BMC Syst Biol 2011, 5:127.
13. Liu ZP, Wang Y, Zhang XS, Chen L. Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains. BMC Syst Biol 2010, 4(Suppl 2):S11.
14. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001, 98(9):5116-5121.
15. Draghici S, Kulaeva O, Hoff B, Petrov A, Shams S, Tainsky MA. Noise sampling method: an ANOVA approach allowing robust selection of differentially regulated genes measured by DNA microarrays. Bioinformatics 2003, 19(11):1348-1359.
16. Fisher RA. Statistical methods for research workers 1932, Edinburgh:Oliver and Boyd, 4.
17. Littell R, Folks J. Asymptotic optimality of Fisher's method of combining independent tests. J Am Stat Assoc 1971, 66(336):802-806.
18. Littell R, Folks J. Asymptotic optimality of Fisher's method of combining independent tests ii. J Am Stat Assoc 1973, 68(341):193-194.
19. Brown M. A method for combining non-independent, one-sided tests of significance. Biometrics 1975, 31(4):987-992.
20. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 2004, 101(7):2173-2178.
21. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Walker DG, Caselli RJ, Kukull WA, McKeel D, Morris JC, et al. Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol Genomics 2007, 28(3):311-322.
22. Armstrong RA. Visual field defects in Alzheimer's disease patients may reflect differential pathology in the primary visual cortex. Optom Vis Sci 1996, 73(11):677-682.
23. Newberg A, Cotter A, Udeshi M, Brinkman F, Glosser G, Alavi A, Clark C. Brain metabolism in the cerebellum and visual cortex correlates with neuropsychological testing in patients with Alzheimer's disease. Nucl Med Commun 2003, 24(7):785-790.
24. Honjo K, van Reekum R, Verhoeff NP. Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease?. Alzheimers Dement 2009, 5(4):348-360.
25. Penzes P, Vanleeuwen JE. Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease. Brain Res Rev 2011, 67(1-2):184-192.
26. Takeichi M, Abe K. Synaptic contact dynamics controlled by cadherin and catenins. Trends Cell Biol 2005, 15(4):216-221.
27. Grace EA, Busciglio J. Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy. J Neurosci 2003, 23(2):493-502.
28. Caltagarone J, Jing Z, Bowser R. Focal adhesions regulate Aβ signaling and cell death in Alzheimer's disease. Biochim Biophys Acta 2007, 1772(4):438-445.
29. Sheng B, Song B, Zheng Z, Zhou F, Lu G, Zhao N, Zhang X, Gong Y. Abnormal cleavage of APP impairs its functions in cell adhesion and migration. Neurosci Lett 2009, 450(3):327-331.
30. Heindel WC, Salmon DP, Shults CW, Walicke PA, Butters N. Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer's, Huntington's, and Parkinson's disease patients. J Neurosci 1989, 9(2):582-587.
31. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010, 362(4):329-344.
32. Malenka RC, Malinow R. Alzheimer's disease: recollection of lost memories. Nature 2011, 469(7328):44-45.
33. Sagar HJ. Clinical similarities and differences between Alzheimer's disease and Parkinson's disease. J Neural Transm Suppl 1987, 24:87-99.
34. Kurup P, Zhang Y, Xu J, Venkitaramani DV, Haroutunian V, Greengard P, Nairn AC, Lombroso PJ. Aβ-Mediated NMDA receptor endocytosis in alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61. J Neurosci 2010, 30(17):5948-5957.
35. Behrens MI, Lendon C, Roe CM. A common biological mechanism in cancer and Alzheimer's disease?. Curr Alzheimer Res 2009, 6(3):196-204.
36. Bennett DA. Is there a link between cancer and Alzheimer disease?. Neurology 2009, 75(13):1216-1217.
37. Plun-Favreau H, Lewis PA, Hardy J, Martins LM, Wood NW. Cancer and neurodegeneration: between the devil and the deep blue sea. PLOS Genet 2010, 6(12):e1001257.
38. Bellucci C, Lilli C, Baroni T, Parnetti L, Sorbi S, Emiliani C, Lumare E, Calabresi P, Balloni S, Bodo M. Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer's disease. Mol Med 2007, 13(9-10):542-550.
39. Gondi CS, Dinh DH, Klopfenstein JD, Gujrati M, Rao JS. MMP-2 downregulation mediates differential regulation of cell death via ErbB-2 in glioma xenografts. Int J Oncol 2009, 35(2):257-263.
40. Lehrer S. Glioblastoma and dementia may share a common cause. Med Hypotheses 2010, 75(1):67-68.
41. Zhu X, Lee HG, Raina AK, Perry G, Smith MA. The role of mitogen-activated protein kinase pathways in Alzheimer's disease. Neurosignals 2002, 11(5):270-281.
42. Chiang HC, Wang L, Xie Z, Yau A, Zhong Y. PI3 kinase signaling is involved in Aβ-induced memory loss in Drosophila. Proc Natl Acad Sci USA 2010, 107(15):7060-7065.
43. Mercado-Gomez O, Hernandez-Fonseca K, Villavicencio-Queijeiro A, Massieu L, Chimal-Monroy J, Arias C. Inhibition of Wnt and PI3K signaling modulates GSK-3beta activity and induces morphological changes in cortical neurons: role of tau phosphorylation. Neurochem Res 2008, 33(8):1599-1609.
44. Oddo S. The ubiquitin-proteasome system in Alzheimer's disease. J Cell Mol Med 2008, 12(2):363-373.
45. Upadhya SC, Hegde AN. Role of the ubiquitin proteasome system in Alzheimer's disease. BMC Biochem 2007, 8(Suppl 1):S12.
46. Casadesus G, Webber KM, Atwood CS, Pappolla MA, Perry G, Bowen RL, Smith MA. Luteinizing hormone modulates cognition and amyloid-β deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta 2006, 1762(4):447-452.
47. Meethal SV, Smith MA, Bowen RL, Atwood CS. The gonadotropin connection in Alzheimer's disease. Endocrine 2005, 26(3):317-326.
48. Chao MV, Rajagopal R, Lee FS. Neurotrophin signalling in health and disease. Clin Sci (Lond) 2006, 110(2):167-173.
49. Coulson EJ. Does the p75 neurotrophin receptor mediate Aβ-induced toxicity in Alzheimer's disease?. J Neurochem 2006, 98(3):654-660.
50. Cruz NF, Ball KK, Dienel GA. Astrocytic gap junctional communication is reduced in amyloid-β-treated cultured astrocytes, but not in Alzheimer's disease transgenic mice. ASN Neuro 2010, 2(4):201-213.
51. Mei X, Ezan P, Giaume C, Koulakoff A. Astroglial connexin immunoreactivity is specifically altered at β-amyloid plaques in beta-amyloid precursor protein/presenilin1 mice. Neuroscience 2010, 171(1):92-105.
52. Webber KM, Casadesus G, Bowen RL, Perry G, Smith MA. Evidence for the role of luteinizing hormone in Alzheimer disease. Endocr Metab Immune Disord Drug Targets 2007, 7(4):300-303.
53. Bai G, Chivatakarn O, Bonanomi D, Lettieri K, Franco L, Xia C, Stein E, Ma L, Lewcock JW, Pfaff SL. Presenilin-dependent receptor processing is required for axon guidance. Cell 2011, 144(1):106-118.
54. Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. Soluble oligomers of amyloid β protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 2009, 62(6):788-801.
55. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008, 14(8):837-842.
56. Layfield R, Cavey JR, Lowe J. Role of ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative disorders. Ageing Res Rev 2003, 2(4):343-356.
57. Lopez Salon M, Morelli L, Castano EM, Soto EF, Pasquini JM. Defective ubiquitination of cerebral proteins in Alzheimer's disease. J Neurosci Res 2000, 62(2):302-310.